Glycerol phenylbutyrate and sodium phenylbutyrate enhance nitrogen excretion, aiding the urea cycle where CPS1 is deficient, without altering the enzyme directly. In contrast, valproic acid can aggravate conditions like hyperammonemia in patients with CPS1 deficiency by inhibiting the urea cycle, increasing ammonia levels.